abstract |
The present invention relates to compounds according to the general formula (1) which bind to the NR1H4 receptor and act as agonists and antagonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and the production of medicaments using said compounds. <CHEM> |